Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications

Chiara Siracusa1, Nicole Carabetta1, Maria Benedetta Morano1

  • 1Department of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.

Insights

Vascular calcification (VC) accelerates in chronic kidney disease (CKD) due to traditional and non-traditional risk factors. Understanding these mechanisms is key to developing new strategies to reduce cardiovascular risk in CKD patients.

Area of Science:

  • Nephrology and Cardiovascular Medicine
  • Biomedical Science

Background:

  • Vascular calcification (VC) involves calcium and phosphate deposition in blood vessel walls, reducing arterial elasticity.
  • VC significantly increases cardiovascular mortality in chronic kidney disease (CKD) patients.
  • Traditional risk factors (age, diabetes, hypertension) and non-traditional factors (oxidative stress, anemia, inflammation) accelerate VC in CKD.

Purpose of the Study:

  • To review traditional and non-traditional risk factors promoting VC in CKD patients.
  • To provide an overview of the pathogenetic mechanisms underlying VC in CKD.
  • To highlight potential new strategies for VC prevention and cardiovascular risk reduction.

Main Methods:

  • Literature review of existing studies on vascular calcification in CKD.
  • Analysis of pathophysiological processes contributing to VC.
  • Discussion of risk factors and inhibitory mechanisms.

Main Results:

  • VC is a critical factor in CKD progression and cardiovascular mortality.
  • Multiple factors, including osteochondrogenic differentiation and imbalances in calcification inhibitors, drive VC.
  • Both conventional and novel risk factors contribute to accelerated VC in CKD.

Conclusions:

  • VC pathogenesis in CKD is multifactorial, involving cellular changes and biochemical imbalances.
  • Identifying and managing traditional and non-traditional risk factors is crucial.
  • Further research into pathogenetic mechanisms may yield novel therapeutic targets for reducing cardiovascular risk in CKD.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
1
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
71
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.1K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339